EUVIMEDEUVIMED entdecken
Crossref

Engineered manganese-BODIPY coordinated nanoadjuvants for enhanced NIR-II photo-metalloimmunotherapy

Yushi Zhang, Xuya Yu, Lingpeng Luo, Yigang Xu, Hanjie Zhang, Zhuo Mao, Yuqin Zhang, Cuihong Yang, Lu Wang, Pengcheng Zhang, Sitong Li, Meitong Ou und 4 weitere

Journal of Controlled Release · 2024-12 · 376 · 1115-1129

DOI: 10.1016/j.jconrel.2024.11.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-12. Verfasst von Yushi Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Na…. Hauptthemen laut MEDLINE: Manganese, Immunotherapy, Boron Compounds, Adjuvants, Immunologic. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Science Fund for Distinguished Young Scholars of Tianjin Municipality, Key Technologies Research and Development Program, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy, a pivotal and promising approach for tumor treatment, has demonstrated prominent clinical efficacy. However, its effectiveness is often impeded by insufficient antitumor immune responses attributed to the immunosuppressive tumor microenvironment (TME). The combination of immune activation through the stimulator of interferon genes (STING) pathway and phototherapy holds great potential for surmounting this challenge in advanced tumor immunotherapy. Herein, a novel manganese-boosted NIR-II photo-metalloimmunotherapy is proposed to synergistically enhance antitumour efficacy by fabricating Mn2+-BODIPY-based coordinated photo-immune nanoadjuvants (BMR), modified with tumor-targeted peptide cRGD. The obtained BMR could effectively deliver Mn2+ to tumor sites, and immunogenic cell death (ICD) was evoked by localized photothermal ablation of tumors using NIR-II laser irradiation. Simultaneously, pH-responsive release of Mn2+ would trigger the activation of STING pathway to promote the production of type I interferons (I-IFNs), significantly facilitating the maturation of dendritic cells (DCs) and polarization of macrophages to M1 phenotypes. Furthermore, by synergistically initiating systematic and robust antitumour immune responses, the BMR-mediated NIR-II photo-metalloimmunotherapy achieved remarkable therapeutic efficacy against both primary and lung metastasis of B16F10 tumors. Overall, in light of the versatile functionalities and synthetic flexibility of coordinated nanoadjuvants, formulated with photofunctional ligands and diverse metal ions, this work provides new insights into the design of metal coordination nanomedicine for effective antitumor photo-metalloimmunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ManganeseImmunotherapyBoron CompoundsAdjuvants, ImmunologicMice, Inbred C57BLAnimalsFemaleInfrared RaysPhototherapyCell Line, TumorMiceTumor MicroenvironmentPeptides, CyclicDendritic CellsNanoparticlesMembrane ProteinsSTING Protein

Stichwörter der Autor:innen

BODIPYCoordination self-assemblyManganese ionNanoadjuvantPhoto-metalloimmunotherapySTING pathway

Substanzen

ManganeseBoron CompoundsAdjuvants, ImmunologicPeptides, CyclicMembrane Proteins4,4-difluoro-4-bora-3a,4a-diaza-s-indacenecyclic arginine-glycine-aspartic acid peptideSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Enginee…
  • Department of General Practice, Xiangya Hospital, Central South University, Changsha, Hunan 410008, PR China.
  • State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking…

Förderung

  • Science Fund for Distinguished Young Scholars of Tianjin Municipality
  • Key Technologies Research and Development Program
  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Tianjin Municipality
  • National Key Research and Development Program of China
  • Tianjin Municipal Science and Technology Program
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Yu, X., Luo, L., Xu, Y., Zhang, H., Mao, Z., Zhang, Y., Yang, C., Wang, L., Zhang, P., Li, S., Ou, M., Luo, R., Zhu, D., Li, W., & Mei, L. (2024). Engineered manganese-BODIPY coordinated nanoadjuvants for enhanced NIR-II photo-metalloimmunotherapy. Journal of Controlled Release, 376, 1115-1129. https://doi.org/10.1016/j.jconrel.2024.11.005

Vancouver

Zhang Y, Yu X, Luo L, Xu Y, Zhang H, Mao Z, et al. Engineered manganese-BODIPY coordinated nanoadjuvants for enhanced NIR-II photo-metalloimmunotherapy. Journal of Controlled Release. 2024;376:1115-1129. doi:10.1016/j.jconrel.2024.11.005

BibTeX
@article{Zhang2024,
  author = {Zhang, Yushi and Yu, Xuya and Luo, Lingpeng and Xu, Yigang and Zhang, Hanjie and Mao, Zhuo and Zhang, Yuqin and Yang, Cuihong and Wang, Lu and Zhang, Pengcheng and Li, Sitong and Ou, Meitong and Luo, Ran and Zhu, Dunwan and Li, Wen and Mei, Lin},
  title = {Engineered manganese-BODIPY coordinated nanoadjuvants for enhanced NIR-II photo-metalloimmunotherapy},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {376},
  pages = {1115--1129},
  doi = {10.1016/j.jconrel.2024.11.005}
}
Kostenlos starten →